Robert Kelly, OD
Optometrist · Marrero, LANPI 1811900756
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Alcon accounts for 93.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $20,919 and has fallen 98.3% since, to $346 in 2025. Among optometrist clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 88 payments — averaging $293.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$24K
- Johnson & Johnson Vision Care, Inc.$453
- Bausch & Lomb, A Division Of Bausch Health US, LLC$270
- Johnson & Johnson Surgical Vision, Inc.$262
- Bausch & Lomb Americas Inc.$242
- Coopervision Inc.$167
- plus $194 from 4 others
What the payments were for
- Consulting fees$14,63057%
- Travel & lodging$8,24332%
- Food & beverage$2,97812%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 70 | $24,264 |
| Johnson & Johnson Vision Care, Inc. | 5 | $453 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $270 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $262 |
| Bausch & Lomb Americas Inc. | 2 | $242 |
| Coopervision Inc. | 2 | $167 |
| Astellas Pharma Global Development | 1 | $113 |
| Oyster Point Pharma, Inc. | 1 | $34 |
| AbbVie | 1 | $24 |
| Shire North American Group Inc | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES$18,790
- Precision 1$2,847
- AIR OPTIX$706
- Acuvue$400
- BIOTRUE$249
- ULTRA$249
- BIOTRUE ONE DAY$249
- EYSUVIS$146
- Tecnis IOL$144
- INFUSE MULTIFOCAL$125
- TearScience Lipiflow System$118
- MIEBO$117
- Izervay$113
How this compares
$25,852 in reported general payments places this provider in the 95th percentile of 500 optometrist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 59 | $75,048 |
| Restasis MultidoseCyclosporine | 30 | $22,759 |
| LumiganBimatoprost | 53 | $22,519 |
| Brimonidine Tartrate | 29 | $5,224 |
| Latanoprost | 482 | $4,065 |
| Alphagan PBrimonidine Tartrate | 11 | $3,307 |
| Travoprost | 24 | $3,292 |
| CombiganBrimonidine Tartrate/Timolol | 15 | $3,162 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 23 | $1,262 |
| Timolol Maleate | 94 | $1,037 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 78 | $986 |
| Prednisolone Acetate | 15 | $977 |
| Dorzolamide Hcl | 27 | $390 |
| MoxifloxacinMoxifloxacin Hcl | 11 | $168 |
| Doxycycline Monohydrate | 11 | $159 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Restasis Multidose, Lumigan, Alphagan P, Combigan | $24 | $126,794168 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 500 optometrist providers in Louisiana.
Other optometrist in Marrero
- Jeffrey WilhiteMarrero$86K
- Pamela TheriotShreveport$207K
- Joshua DavidsonGonzales$189K
- Christopher WrotenHammond$59K
- James LamarNew Orleans$45K
- John McCallLogansport$32K
- Shane FontenotJennings$23K
- Stephen LewisShreveport$17K
- Breanne McGheeNew Orleans$14K
- Robert JanotSulphur$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.